Alcon Inc. (ALC.SW)

72,12 0,00 (0,00%) Ab 12:55PM CEST. Markt geöffnet.

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva 1214
Switzerland
41 589 112 110
https://www.alcon.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 25.315

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. F. Michael Ball	Executive Chairman	1,06M	N/A	1955
Mr. Arthur B. Cummings M.D.	Executive Director	259,27k	N/A	1962
Mr. David J. Endicott	CEO & Director	4,39M	N/A	1965
Mr. Timothy C. Stonesifer	Chief Financial Officer	N/A	N/A	1967
Margaret Buckley	Chief Accounting Officer	N/A	N/A	N/A
Dr. Franck Leveiller	Senior VP, Head of Global R&D and Chief Scientific Officer	N/A	N/A	N/A
Ms. Sue-Jean Lin	Senior VP and Chief Information & Transformation Officer	N/A	N/A	1959
Mr. Royce R. Bedward	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1966
Ms. Kimberly Martin	Senior VP, Chief HR Officer & Corporate Communications	N/A	N/A	1975
Mr. Laurent Attias	Head of Corporate Development, Strategy, BD&L and M&A	N/A	N/A	1968

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in CHF.

Beschreibung

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Corporate Governance

Alcon Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 2. Die grundlegenden Scores sind Audit: 5, Vorstand: 3, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.